Clinical Genitourinary Cancer
Издатель: Elsevier · ISSN 1558-7673 · 77 статей
- Early Achievement of Ultra-low PSA Levels Correlates With Prolonged Radiologic Progression-free Survival (rPFS) in Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
- Real-World Efficacy and Safety of Belzutifan in Sporadic Metastatic Renal Cell Carcinoma
- Utility of Circulating Tumor DNA as a Monitoring Tool for Marker-Negative Germ Cell Tumors and Somatic Type Malignancies
- Prognostic Value of Androgen Receptor (AR) Gene Alterations Detected in Circulating Tumor DNA (ctDNA) in Patients With Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and Meta-analysis
- Expression of Antibody–Drug Conjugate Targets in Urachal and Primary Bladder Adenocarcinomas
- Is Peri-Renal Fat Thickness Associated With Progression to Chronic Kidney Disease After Radical Nephrectomy?
- Patient Longevity Outcomes of Conservative Strategies Versus Radical Prostatectomy for Localized Prostate Cancer: A Meta-analysis With Trial Sequential Analysis
- Impact of Preoperative Sarcopenia on Survival and Perioperative Outcomes After Radical Cystectomy for Bladder Cancer
- The Prognostic Impact of Circulating Tumor DNA in Metastatic Urothelial Cancer
- Trilaciclib With Platinum-based Chemotherapy Followed by Avelumab Maintenance as First-line Treatment in Patients With Locally Advanced or Metastatic Urothelial Carcinoma: PRESERVE 3 Phase II Trial
- Prognostic Relevance of Soluble B7-H3/CD276 in Prostate Cancer Patients With Bone Metastases
- Early Real-World Outcomes and Safety of Belzutifan in Japanese Patients With Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Study
- Molecular Heterogeneity of Aggressive Prostate Cancer: Insights from an Age- and Race-Matched Radical Prostatectomy Cohort
- Within-patient changes in serum concentrations and patient-reported outcomes following symptom-guided enzalutamide dose reduction from 160 to 120 mg
- Growing Teratoma Syndrome in Testicular Germ Cell Tumors: From Classical Definition to Molecular Biology and Modern Management
- Histological Subtypes, Divergent Differentiation, and Neuroendocrine Components in Primary Non-Muscle-Invasive Bladder Cancer Managed with Bladder-Preserving Approaches: A Propensity Score-Matched Study
- Evaluation of a Large Language Model for Clinical Decision Support: Agreement with Multidisciplinary Tumor Board Recommendations in Metastatic Hormone-Sensitive Prostate Cancer
- The Prognostic Significance of Young Age in Prostate Cancer: A Propensity Score-Matched Analysis of the SEER Database
- Assessing the Impact of 89Zr-Girentuximab PET/CT on Stated Management Preferences: Results from an Exploratory Survey of Urologic Oncologists
- Real-World Determinants of Therapeutic Choice in Metastatic Renal Cell Carcinoma: A Machine Learning Analysis of Practice Patterns from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC)
- Pre-existing Metabolic Syndrome and Cardiometabolic Outcomes in Metastatic Hormone-Sensitive Prostate Cancer: A Retrospective Cohort Study Using the TriNetX Network
- Cardiovascular Adverse Event Reporting Signals Associated with Concomitant Use of Androgen Receptor Pathway Inhibitors (ARPIs) And Cardiovascular Treatments
- Baseline Cardiovascular Risk, Body Composition Changes, and Survival Outcomes During Intensified Androgen Deprivation Therapy in Locally Advanced and Metastatic Hormone Sensitive Prostate Cancer
- Safety and Efficacy of Immune Checkpoint Inhibitors Plus Bacillus Calmette–Guérin for High-Risk Non–Muscle-Invasive Bladder Cancer: A Bayesian Re-analysis of a Published Frequentist Meta-analysis
- Efficacy and Safety of Second-Line Cabozantinib After IO-IO Versus IO-TKI Combination Therapy and the Impact of Reduced Starting Dose in Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Study
- Comparison of Three Maintenance Protocols for First-line Intravesical Gemcitabine in Asian Patients with Non-muscle-invasive Bladder Cancer: A Multicenter, Retrospective Cohort Study
- Longitudinal somatic mutational dynamics in ctDNA from patients with metastatic castration-resistant prostate cancer receiving androgen receptor–directed therapy
- Treatment Patterns and Survival Outcomes in Urachal Carcinoma: A Multicenter Real-World Study of 50 Patients from the West Japan Uro-oncology Collaboration Group
- Clinical characteristics and treatment patterns in cisplatin-eligible versus cisplatin-ineligible muscle-invasive bladder cancer patients with intent for resection: A multi-country retrospective chart review in Europe
- Systemic Therapies in Docetaxel-Naïve, Biomarker-Unrestricted Metastatic Castration-Resistant Prostate Cancer (mCRPC) after Prior Androgen Receptor Pathway Inhibitor (ARPI) or Androgen Deprivation Therapy (ADT): A Systematic Literature Review (SLR) and Indirect Treatment Comparison (ITC)